Primary phase 2 efficacy and safety results of M-Pola in relapsed/refractory LBCL Presented ByDr Elizabeth Budde, City of Hope National Medical Center, CA, USA TrialPhase 1/2 ConferenceASH 2023 7 February, 2024 14:59
Mosunetuzumab: complete remissions in non-Hodgkin lymphoma Presented ByProf. Stephen Schuster, University of Pennsylvania, USA ConferenceASH 2019 5 March, 2020 09:50